Literature DB >> 22237379

Breast and abdominal adipose multipotent mesenchymal stromal cells and stage-specific embryonic antigen 4 expression.

Jacquelyn R Maddox1, Katherine D Ludlow, Feng Li, Christopher Niyibizi.   

Abstract

We assessed human mesenchymal stem cells (MSCs) harvested from breast and abdominal adipose tissues enriched in embryonic stage-specific antigen (SSEA-4) expression for osteogenic and adipogenic differentiation in comparison to a mixed cell population. Human adipose was obtained from abdominal and breast tissues of females undergoing gastric bypass and breast reduction, respectively. SSEA-4-expressing cells were enriched from the mixed cell population by magnetic cell sorting and expanded in culture. The results showed that freshly isolated cells from breast and abdominal tissues based on adipose from 3 patients comprised 12 and 10% SSEA-4+ cells, respectively. At passage 0, 48% of the cells from breast adipose tissue were positive for SSEA-4 while 12% of the cells from abdominal adipose tissue were positive for this antigen. The level of SSEA-4-expressing cells remained relatively constant with passaging; SSEA-4-expressing cells from breast tissue comprised 45% of the total while 27% of the cells from abdominal adipose tissue expressed SSEA-4 at passage 5. Cells sorted for SSEA-4 expression exhibited a higher potential for differentiation toward osteogenic and adipogenc cell lineages in vitro when compared to a mixed population. Interestingly, SSEA-4 expression was lost upon differentiation, suggesting that the antigen marks a subpopulation of MSCs. Taken together, the data demonstrate that breast adipose tissue is highly enriched in a subpopulation of MSCs expressing SSEA-4 and suggest that SSEA-4 may be a marker of a subpopulation of MSCs with high potential for osteogenic and adipogenic differentiation.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237379      PMCID: PMC3564522          DOI: 10.1159/000331332

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  36 in total

1.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.

Authors:  S Gronthos; M Mankani; J Brahim; P G Robey; S Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging.

Authors:  Svetlana Halfon; Natalie Abramov; Borislava Grinblat; Irene Ginis
Journal:  Stem Cells Dev       Date:  2010-10-26       Impact factor: 3.272

Review 3.  Attributes of adult stem cells.

Authors:  M R Alison; S Islam
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

4.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

Review 5.  Concise review: Adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation.

Authors:  Jeffrey M Gimble; Bruce A Bunnell; Ernest S Chiu; Farshid Guilak
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

6.  Targeting improves MSC treatment of inflammatory bowel disease.

Authors:  In Kap Ko; Byung-Gyu Kim; Amad Awadallah; Jenifer Mikulan; Paul Lin; John J Letterio; James E Dennis
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

Review 7.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

8.  Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche.

Authors:  Yanming Bi; Driss Ehirchiou; Tina M Kilts; Colette A Inkson; Mildred C Embree; Wataru Sonoyama; Li Li; Arabella I Leet; Byoung-Moo Seo; Li Zhang; Songtao Shi; Marian F Young
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

9.  Glycan stem-cell markers are specifically expressed by spermatogonia in the adult non-human primate testis.

Authors:  T Müller; K Eildermann; R Dhir; S Schlatt; R Behr
Journal:  Hum Reprod       Date:  2008-07-10       Impact factor: 6.918

Review 10.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

View more
  5 in total

Review 1.  Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitro.

Authors:  Patrick C Baer
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

2.  Isolation and characterization of SSEA-4-positive subpopulation of human deciduous dental pulp cells.

Authors:  Noriaki Kawanabe; Hiroaki Fukushima; Yoshihito Ishihara; Takeshi Yanagita; Hiroshi Kurosaka; Takashi Yamashiro
Journal:  Clin Oral Investig       Date:  2014-05-27       Impact factor: 3.573

Review 3.  Enabling stem cell therapies for tissue repair: current and future challenges.

Authors:  Victor W Wong; Michael Sorkin; Geoffrey C Gurtner
Journal:  Biotechnol Adv       Date:  2012-11-22       Impact factor: 14.227

Review 4.  Adipose-derived stem cells: selecting for translational success.

Authors:  Kavan S Johal; Vivien C Lees; Adam J Reid
Journal:  Regen Med       Date:  2015       Impact factor: 3.806

5.  Ex Vivo Human Adipose Tissue Derived Mesenchymal Stromal Cells (ASC) Are a Heterogeneous Population That Demonstrate Rapid Culture-Induced Changes.

Authors:  Anna E S Brooks; Megan Iminitoff; Eloise Williams; Tanvi Damani; Victoria Jackson-Patel; Vicky Fan; Joanna James; P Rod Dunbar; Vaughan Feisst; Hilary M Sheppard
Journal:  Front Pharmacol       Date:  2020-02-20       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.